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ABSTRACT
One of the most significant threats to the well-being and performance of grazing livestock
are gastrointestinal nematode (GIN) parasitic infections. Allowing a large GIN burden to manifest
can cause a significant cost in terms of productivity in grazing cattle. Beef producers commonly
rely greatly on the efficacy of broad-spectrum anthelmintics, to not only kill resident worms but to
also prevent the establishment of ingested infective stage larvae (L3) for a period following
treatment. Eprinomectin (LONGRANGE®, E-LR) is the first extended-release injectable cattle
dewormer that claims to provide cattle producers season-long persistent parasite control for 100 to
150 d in a single dose, dependent on parasite species. This in turn, improves nutritional efficiency.
The purpose of this study is to evaluate the efficacy of E-LR for controlling long-term GIN
infections in nursing calves. E-LR was compared to the traditional anthelmintic fenbendazole
(Panacur®, F-P). Four groups of nursing calves (with their dams) grazed separate pastures and
pastures were rotated after each sampling date to ensure equal parasitic pasture exposure. Two
groups were treated with E-LR and two groups were treated with F-P. Calves were weighed at 28 d
intervals and fecal samples were collected on d 0, 14, 28, 56, 84, and 112. Results indicated E-LR
was effective in providing long term parasite control. There was no significant (p < 0.05) difference
in the FEC between F-P and E-LR treated animals on d 14, showing that both were efficient at
initially killing GIN. Significant differences in FEC between treatments started to show by d 56. On
d 56, there was an increase in FEC in calves treated with F-P which continued to increase
throughout the rest of the study. The E-LR treated animals had only slightly increased FEC for the
rest of the study which indicated prolonged GIN control.

ix

CHAPTER 1
INTRODUCTION
Gastrointestinal nematodes (GIN) are parasites that have caused disease and production
losses in many different types of animals including ruminants. Cows, sheep, and goats are just a
few of the ruminants that can become infected with GIN while grazing. The GIN parasites that
affect livestock have an obligatory free-living part of the life stage where larval development to
the infective larval stage (L3) takes place on pasture. The phylum Nematoda includes many
parasites that are of major socio-economic importance including Haemonchus spp., Ostertagia
spp., Trichostrongylus spp., Cooperia spp., and Oesophagostomum spp. Depending on the
species and burden of these parasites, they can cause potentially fatal diseases such as parasitic
gastroenteritis (PGE) (Taylor et al, 2007). Common signs of PGE include reduced weight gain or
weight loss, anorexia, diarrhea, reduced production and, in the case of blood-feeding species,
anemia and edema, due to the loss of blood and/or plasma proteins (Taylor et al., 2007). Every
GIN present within the host has been acquired by the ingestion of L3 present on the pasture
(Waller, 2006). While grazing on infective pastures, ruminants are exposed to varying numbers
of L3 and can consume very high numbers leading to heavy GIN burdens.
This can constitute a significant threat to the health and welfare of grazing livestock
throughout much of the world and impose a significant cost in terms of productivity in grazing
cattle (Perry, 2002; Dijk et al, 2010). GIN infections in countries like the United States have
accounted for losses around $330 million USD/year (Seó, 2015). Young animals, such as calves
and replacement heifers, are the most susceptible to GIN infection and the negative effects
include decreased weight gain and delay in reproduction. Any delay in breeding and calving can
also dramatically increase rearing costs by as much as $50 per heifer for each month beyond 24
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months of age (Van Amburgh, 2001; Looper and Bethard, 2005.). Lawrence et al. (2009),
showed that the prevention and treatment of GIN can result in up to a $201 gain per head of
cattle.
There can be much variation in the level of GIN depending on the animal and its
geographic location. Multiple studies have shown that the most highly parasitized ruminants in
the country are located in areas where the climate is hot and humid. Heavily stocked pastures
and/or limited acreage can also result in higher GIN burdens, particularly in these mild and moist
conditions (Williams, 1986). Younger animals are more likely to display clinical signs of
parasitism, while adult animals are more likely to have subclinical infections that may impact
their performance and profitability. Age, climate, living conditions, and timing are some aspects
to consider in determining an appropriate GIN management plan (Gould, 2009).
Conventional methods of controlling GIN parasites of grazing livestock have been
through the use of synthetic chemotherapeutic drugs (anthelmintics). Because of the continual
developments of increased anthelmintic efficacy, better safety, and broader spectrum of activity
along with increased cost effectiveness, livestock producers have relied almost exclusively on
their use (Morley and Donald, 1980; Waller, 1993). Though this approach has been successful,
many reports of anthelmintic failure suggest that traditional deworming methods are short
sighted and unsustainable. Additionally, the overuse of these anthelmintics has led to numerous
reports of drug resistance that include every livestock host and every anthelmintic class. In some
regions of the world, the high prevalence of multi-drug resistance (MDR) in GIN of sheep and
goats threatens the viability of small-ruminant industries (Kaplan, 2004). According to
Sutherland and Leathwick (2011), escalating reports since 2005 suggest that GIN anthelmintic
resistance in cattle is a rapidly increasing problem. For example, benzimidazole resistance was
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identified in cattle in New Zealand (Jackson et al, 2006) and South America (Suarez et al, 2007).
Macrocyclic lactone (ML) resistance was found in New Zealand (Vermunt et al, 1996;
Loveridge, 2003) the Americas (Gasbarre et al, 2009; Edmonds et al, 2010) and Europe
(Demeler et al, 2009). However, there have only been a few detailed reports in the U.S.
identifying reduced anthelmintic efficacy and increasing resistance in ruminants. Therefore, the
extent of the problem in the U.S remains largely unknown and may be grossly underestimated in
cattle.
Most conventional anthelmintics are short acting and do not stay at therapeutic levels in
animals long enough to provide protection for an extended length of time thus requiring frequent
use. The most commonly used anthelmintics remain efficacious for short periods of time
ranging from 3-5 to 42 d. This shorter time length typically is not long enough to reduce the
amount of GIN L3 on the pasture. In the large picture, GIN parasite programs involving frequent
treatments are not convenient nor efficacious as it requires excessive handling of cattle.
Excessive handling, especially during hot summer months, places more stress on the animals
which can have deleterious effects on cattle health, productivity and welfare (Mader, 2006). In
addition, frequent use of traditional anthelmintics contribute to the selection pressure placed on
resistant GIN. Hence, with the increasing challenge of GIN control in cattle, there is an urgent
need to develop a different approach for parasite control to maintain long term drug
sustainability in cattle and reduce selection pressure of resistant GIN.
Merial, a multinational animal health company, has produced an extended release
injectable anthelmintic that offers 100 to 150 d of GIN protection with one single dose.
Eprinomectin (LONGRANGE®, E-LR) is formulated in a polymer matrix, which aids in pulse
release of the active ingredient following injection. Merial claims that a single spring treatment
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works long enough to break the parasite life cycle and reduce pasture reinfection. Because of the
length of protection that E-LR offers, it also aims to reduce the labor costs and stress associated
with handling and treating animals.
The objectives of this study were 1) to evaluate the anthelmintic efficacy of E-LR at the
recommended dose of 1 mg/kg of body weight in nursing calves during summer grazing in
comparison to fendendazole (Panacur®, F-P) and 2) to evaluate the effect of E-LR compared to FP on weight gain in nursing calves during summer grazing.
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CHAPTER 2
LITERATURE REVIEW
2.1 Trichostrongyle Type Parasites
Trichostrongyle type parasites have been found to be the most economically significant
GIN in small and large ruminants (Gibbs, 1987). Heavily parasitized calves are unhealthy in
appearance and usually have a dry, dull hair coat. Growth and feed efficiency are also
substantially reduced. Anemia, diarrhea, weight loss and death may occur when infection is
severe. Small and large ruminants are hosts to a number of GIN within the Phylum Nematoda
with slight variations (Sutherland et al, 2009). Differences in host preference occur within GIN
species. Cattle can be hosts to at least 14 GIN and the major threat to the animal’s health and
performance comes from those found in the abomasum and small intestines. Members of the
trichostrongyle type GIN group in cattle that cause the most damage are Haemonchus placei
(barber pole worm), Ostertagia ostertagi (medium or brown stomach worm), Trichostrongylus
axei (small stomach/bankrupt worm), Oesophagostomum radiatum (nodular worm), and many
species of Cooperia including C. punctata, C. oncophora, and C. pectinata. (Craig, 2009). H.
placei is primarily a parasite in tropical regions, whereas O. ostertagi and, to a lesser extent, T.
axei are found in more temperate climates. These nematodes are small, thread-like worms that
are found in the abomasum. Species of Cooperia are usually found in the small intestine in cattle,
while O. radiatum is found in the caecum and large intestine in cattle (Ballweber, 2001; Gibbs,
1986). Although some details vary, GIN of cattle have a direct life cycle and follow a similar
pattern. Having a direct life cycle means that the parasite does not require an intermediate host to
complete the life cycle. In other words, the parasite will only need to infect one animal to
complete its life cycle.
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2.1.1 Life Cycle of Trichostrongyle Type Nematodes in Cattle
Adult worms in the abomasum or intestinal tract can produce millions of microscopicsized eggs that are passed in the feces. Under favorable environmental conditions, these eggs
hatch in feces and form into the free living larval stages, 1st larval stage (L1), 2nd larval stage
(L2), and 3rd larval stage (L3). The immature L1 and L2 continue to feed and develop in feces
on pastures until they reach the ensheathed L3. The sheath protects the L3 stage from
environmental conditions but prevents it from feeding (Taylor, 2007). When proper moisture, via
rain, dew, or irrigation, is available, the L3 migrate out of the feces and onto surrounding
vegetation. L3 larvae are then ingested by grazing animals. Depending on the species of the
parasite, the development from L1 to L3 takes less than 14 d under optimal conditions (Craig,
2009). The L3 larvae loses its protective sheath in the rumen and invades the mucosa of the
abomasum or intestinal tract where it develops to the fourth stage larvae (L4). The L4 emerge
from the mucosa and eventually mature into adult worms in the lumen (Schmidt, 2013). The
cycle is then repeated when the adult worms mate and produce eggs that are passed in the feces
producing the next generation. Depending on the GIN present, the life cycle can take up to 6
weeks to complete (Ballweber, 2001).
2.1.2 Haemonchus placei
Haemonchus is a genus of parasitic roundworms that infect cattle, sheep and goats as
well as other wild ruminants. Nematodes of this genus are also called the barber pole worm,
twisted wireworm or large stomach worm. They are found worldwide but are more frequent and
harmful in regions with tropical and subtropical humid climates. The most relevant species for
livestock are H. contortus and H. placei. While both of these species can infect small and large
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ruminants, H. placei primarily targets cattle. The adults are 20-30 mm in length (Craig, 2009).
The mouth of Haemonchus worms have a small pointed lancet for disrupting capillaries in the
mucosal tissues to allow blood flow for feeding purposes (Urquhart, 2007).
After the L3 are ingested, they move to the abomasum, penetrate the abomasal mucosa
and develop to L4. L4 return to the lumen and mature to adults. L4 and adults both feed on blood
flowing out of the lesions they cause to the abomasal mucosa with their lancet mouthparts
(Taylor, 2007). The blood loss can be extensive enough to result in anemia. Females can produce
up to 10,000 eggs daily. L4 larvae can become dormant (sometimes called hypobiosis or
inhibited development) in the abomasal tissues as a means of survival in that cold and/or dry
environmental conditions outside the host are not conducive for completion of the life cycle.
They resume development to adults after 3-4 months when environmental conditions become
more favorable. One of the clinical signs of chronic infection is edema, i.e. accumulation of
liquid in the abdomen, thorax, and submandibular tissue. Submandibular edema is referred to as
"bottle jaw" and is characteristic of infections with Haemonchus and some other GIN. Severe
infections can also cause liver damage, weight loss, unthriftiness, diarrhea and dehydration
(Schmidt, 2013).
The prepatent period for H. placei is around 21-28 d, while H. contortus prepatent period
is approximately 18-21 d. This short life cycle allows several generations in one season and can
rapidly increase pasture infectivity. Most Haemonchus infections are mixed with other GIN
which worsen the damage caused to affected livestock (Ballweber, 2001).
2.1.3 Trichostrongylus spp.
Trichostrongylus is a genus of GIN belonging to the family Strongylidae that affects
cattle, sheep, goats and other ruminants, as well as pigs, horses and poultry. T. axei, also known
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as the bankrupt worm, is the predominant species of Trichostrogylus in cattle. It prefers to
inhabit the abomasum but can occasionally be found in the small intestine (Schmidt, 2013).
Adult Trichostrongylus worms have a slender form and a brownish-reddish color and are 5 to 10
mm long. The prepatent period is about 20-25 d.
L3 can survive in the environment and remain infective for up to 6 months and
sometimes longer. After ingestion of L3, T. axei complete development to adult worms in the
abomasum, similar to that of Haemonchus. L3 of other species of Trichostrongylus reach and
reside in the small intestines, where they enter the crypts of the mucosa, molt to L4 and emerge
back into the lumen to complete development into adult worms. Trichostrongylus worms
damage the mucosa of the abomasum and small intestine of the host leading to gastritis, enteritis,
and sometimes anemia. Typical signs are diarrhea (mucous and/or hemorrhagic) or constipation,
general weakness and wasting, loss of appetite, reduced weight gains or even weight loss, etc.
Acute severe infections in young animals may be fatal (Ballweber, 2001).
2.1.4 Oesophagostomum radiatum
Oesophagostomum, belongs to the family Strongylidae. These worms are called "nodular
worms" because they cause the characteristic appearance of nodules in the small and large
intestine of their host (Schmidt, 2013). Adult nematodes are stout and are 15-20 mm long. The
prepatent period of Oesophagostomum is around 41 d. After eggs are shed in feces, development
from L1 to L3 takes about 1 week. After ingestion, L3 penetrate the intestinal mucosa and the
host response is to form nodules or granulomas around the developing larvae (Sutherland et al,
2009; Ballweber, 2001). The L4 complete their life cycle to adults by emerging from the nodules
and return to the lumen of the colon where they mate and females produce eggs. The eggs and
developing larvae are susceptible to dry conditions and extreme temperatures, but can survive up
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to 3 months, and sometimes longer, on pasture. Intestinal nodule formation disrupts the normal
physiology of the gut, particularly the absorption of liquids, which leads to diarrhea, but can also
have an effect on peristaltic movements. Deadly bacterial infections can result if the large
intestinal nodules burst through the intestinal wall and release gastrointestinal contents into the
abdominal cavity. Young animals in particular are affected most severely by this GIN.
2.1.5 Cooperia spp.
Several species of Cooperia are found in the small intestine of cattle; C. punctata, C.
oncophora, and C. pectinata are the most common. Adult Cooperia have a reddish color, are up
to 10 mm long, and are often coiled (Craig, 2009). The prepatent period of this nematode is 1215 d. Cooperia L3 can survive up to 12 mo, and sometimes longer, on pasture, which makes it
quite difficult to reduce the populations. L4 may become inhibited for up to 5 mo before
completing development. This makes it possible for those larvae that infect the animal at the end
of the summer to remain inside the animal during the winter and to resume development in the
next spring when more favorable environmental conditions exist. In heavy infections with C.
punctata and C. pectinata, there is profuse diarrhea, anorexia, and emaciation, but no anemia
(Keith, 1987).
2.1.6 Ostertagia ostertagi
Ostertagia ostertagi is the most economically important GIN of cattle in temperate parts
of the world (Craig, 2009). Adult males measure 6-8 mm, adult females are approximately 8-11
mm in length. The prepatent period of O. ostertagi is approximately 18-25 d. The life cycle is
typical of that described for Haemonchus. In northern temperate cooler regions, ingested L3
typically go into hypobiosis during the winter when the temperature is too cold for development
and survival outside the host. In warmer regions, hypobiosis occurs over the summer when
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conditions may be too hot and dry for the development and survival outside the host. They can
remain dormant for 4-5 mo (Duncan, 1987; Corwin, 1993). Large numbers of hypobiotic L4 can
potentially accumulate during this time. When environmental conditions are favorable these L4
rapidly increase in size, emerge in large numbers and can cause massive destruction to the
abomasum, leading to severe disruption of function. Feed conversion may become compromised
and subsequently affect weight gain, body maintenance, reproductive fitness and milk
production. (Vercruysse, 1997). The host can become clinically ill with anemia, edema, loss of
appetite, and in severe cases, death.
Three forms of disease with this parasite are well recognized and include ostertagiasis
Type I, Pre-type II, and Type II. In Type I ostertagiasis, most worms present in the animal are in
the adult stage. This is due to the direct development of large numbers of L3 to adult worms over
a relatively short period of time. Type I disease is seen primarily in calves 7–15 months old on
pasture. It is most commonly seen during late fall and winter after calves are weaned in
temperate regions and in calves during late summer and early fall in cool temperate regions. Pretype II ostertagiasis is asymptomatic occurring when infected animals carry large populations of
inhibited L4. Type II ostertagiasis is characterized by the emergence of large numbers of
inhibited L4 during the spring in cool temperate regions and during the fall in warm temperate
regions. Thus, in warm temperate regions, inhibition-prone L3 are acquired during spring
grazing where development to adults resume in late summer and/or fall, and in cold temperate
regions, inhibition-prone L3 are acquired during late autumn and mature during late winter
and/or early spring (Meyers et al., 1989).
2.2 Anthelmintic Control of Gastrointestinal Nematodes
Anthelmintics are a group of antiparasitic drugs that expel worms from the body by either
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paralyzing or killing them. This is done without causing damage to the host. Parasite control in
livestock relies on the use of antiparasitic drugs, which comprise the largest sector of the animal
pharmaceutical industry (Waller, 2006). The excellent broad spectrum efficacy, good tolerance,
and low costs of available anthelmintics have accounted for the extensive use of chemical control
in livestock animals over the past decades. The economic benefit of anthelmintics in the U.S.
beef cattle industry was reviewed by Lawrence and Ibarburu (2007). Their conclusion over 170
published articles, according to 2005 market prices, indicated that the removal of antiparasiticides from the U.S. beef production would result in increased production costs of nearly
$190 per head. This study review validated the importance of effective parasite control, and
shows reduced anthelmintic efficacy poses a definite concern. New pharmacokinetic properties
of anthelimintics are being developed which make them more reliable and convenient in terms of
delivery and labor costs.
Currently, three major classes of anthelmintics are available for use in cattle including
benzimidazoles (albendazole, fenbendazole, and oxfendazole), imidazothiazoles (levamisole),
and macrocyclic lactones. Macrocyclic lactones are divided into two groups: first-generation
avermectins (ivermectin, doramectin, eprinomectin, and abamectin), and second-generation
milbemycins (moxidectin) (Edmonds, 2010).
2.2.1 Benzimidazoles
The benzimidazole class was the first anthelmintic introduced into the animal health
market in the early 1960’s (Campbell, 1990). Benzimidazoles are heterocyclic aromatic organic
compounds produced by the synthesis of benzene and imidazole. They were formulated not only
for use in farm animals but also for companion animals. Drugs in this class include thiabendazole
(TBZ®), fenbendazole (Panacur®, Safeguard®), albendazole (Valbazen®), oxfendazole
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(Synanthic®), mebendazole, flubendazol, oxibendazole, albendazole sulfoxide, thiophanate,
febantel, netobimin, and triclabendazole (Kahn, 2005).
Benzimidazoles cause degenerative alterations in the tegument and intestinal cells of the
parasite by binding to the tubulin, thus inhibiting its assembly into microtubules (Lacey, 1988).
The loss of microtubules leads to impaired uptake of glucose by the larval and adult stages of the
susceptible worms, and depletes their glycogen stores. Due to diminished energy production, the
worm is immobilized and eventually dies (Martin, 1997).
The benzimidazole class of anthelmintics rapidly grew popular amongst livestock
producers because they offered major benefits over previous drugs such as breadth of spectrum,
efficacy against many life stages of the parasite, and safety for the animal host (Campbell, 1990).
Benzimidazoles have a huge safety margin thereby making them an ideal choice for routine use.
Members of this class are effective against adult, larval stages, and inhibited larval stages of GIN
(Bogan and Armour, 1987).
Benzimidazoles also exhibited some effect on reducing pasture contamination in that
eggs shed on pasture failed to hatch after being exposed to drugs in this class. (Campbell, 1990;
Miller and Morrison, 1992b). Some benzimidazoles offer an extended spectrum, with activity not
only against GIN but also against other intestinal and liver helminths such as tapeworms and
flukes (Campbell, 1990). In general, benzimidazoles are poorly effective against Trichuris spp.
in ruminants (Campbell, 1990). Currently, thiabendazole (TBZ®), fenbendazole (Panacur®,
Safeguard®) albendazole (Valbazen®), and oxfendazole (Synanthic®) are approved for use in
cattle by the Food and Drug Administration (FDA).
Benzimidazoles are absorbed from the GI tract and, after passage through the liver, the
drugs or their metabolites are returned to the rumen and small intestine. The rate of absorption
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and excretion varies widely from drug to drug, with slower absorption and prolonged recycling
between enteral and parenteral tissues appearing to enhance efficacy. The relative rates of
oxidation in the liver and reduction in the GI tract vary between cattle and sheep (Lanusse,
1993). Metabolism and excretion of benzimidazoles are more extensive in cattle than in sheep.
Subsequently, the efficacy and length of parasite protection of most drugs in this class has shown
to work better in sheep than in cattle. Albendazole, fenbendazole, oxfendazole, and febantel are
said to be active against inhibited L4 of Ostertagia spp; however, inconsistent efficacy has been
reported (Miller, 1993).
Typically, benzimidazoles have been administered in the form of a single oral drench.
More recently, delivery methods have moved away from the traditional single oral drench
concept. For example, benzimidazole products now include bolus, pastes, powders, feed
premixes, etc. The simplest delivery method is to incorporate the drug into feed blocks for
ingestion in small amounts over a prolonged grazing period. This method of drug presentation
can lead to variations in the amount of drug each animal receives and is generally not
recommended. More sophisticated approaches have involved the use of a special syringe to inject
the drug directly into the rumen of cattle. Several devices have been developed that are
introduced into the rumen by mouth and release the active benzimidazole drug in a sustained or
intermittent manner for a prolonged period (Campbell, 1990; Lanusse, 1993).
The intraruminal injector is a plastic syringe in which a needle is inserted into the rumen
cavity where a dose of oxfendazole is released. Other intraruminal devices deliver the drug by
mouth and is retained in the rumen. One such device, delivers oxfendazole in pulses spaced
approximately 3 wk apart over a period of approximately four months. This is achieved by the
continuous galvanic corrosion of a magnesium alloy rod that periodically exposes an annular
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oxfendazole tablet to the intraruminal fluid. There has also been a delivery system that
periodically releases albendazole at monthly intervals over a 3 mo period (Campbell, 1990).
The overall margin of safety has contributed to the success of benzimidazoles worldwide
over the last few decades. However, the principle concern with this class of anthelmintic is the
emergence of GIN that have become resistant to the effects of treatment.
2.2.2 Nicotinic Antagonists
Another widely-used class of anthelmintics are the nicotinic antagonists which include
the imidazothiazoles such as levamisole (Prohibit®, Levasol®, and Tramisol®), the
tetrahydropyrimidines such as morantel tartrate (Rumatel®,and Nematel®), and pyrantel panoate
(Strongid®) (Schoenian, 2012). These compounds act selectively as agonists of synaptic and
extrasynaptic nicotinic acetylcholine receptors on nematode muscle cells (Martin, 1997).
Currently, levamisole is the only FDA-approved anthelmintic in this class for use in cattle and
sheep, and morantel tartrate is the only FDA-approved drug in this class for use in goats
(Schoenian, 2012).
Levamisole is the main drug in this class used for cattle. Its broad spectrum of activity,
ease of use (being water soluble), and lack of teratogenic effects have allowed it to be used
successfully. Levamisole also has an immunostimulant effect which may enhance disease
control. One disadvantage is at dosage rates higher than that recommended for anthelmintic
activity, animals can develop signs of neurological impairment, so its margin of safety is not as
wide as the benzimidazoles or macrocyclic lactones. Levamisole acts as a nicotinic receptor
agonist and eliminates GIN by causing parasite muscle paralysis. It has some efficacy against
lungworms but no activity against flukes and tapeworms and is not ovicidal (Lanusse, 1993).
Levamisole can be delivered in different forms such as oral, topical, or injectable. The
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absorption and excretion of levamisole is rapid and not affected by the route of administration or
ruminal bypass because of its high solubility. It is effective against many parasite life stages such
as adults and larval stages but lacks activity against arrested or hypobiotic larvae, such as those
of O. ostertagi. In cattle, blood concentrations of levamisole peak less than one hour after
subcutaneous administration. These concentrations decline rapidly resulting in the excretion of
90% of the total dose within 24 hours primarily through urine (Arundel, 1983). The
tetrahydropyrimidine group exhibits activity against primarily adult GIN. Pyrantel tartrate is well
absorbed by pigs and dogs, and less well by ruminants. The pamoate salt of Pyrantel is poorly
soluble in water which causes reduced absorption in the gut and allows the drug to reach and be
effective against parasites in the large intestine, which makes it useful in horses and dogs (The
Merck Veterinary Manual, 2014). Pyrantel is administered by mouth as a suspension, paste,
drench, or tablets. Morantel is the methyl ester analog of pyrantel poamoate and is known to be
safer in ruminants than its counterpart. It is absorbed rapidly from the upper small intestine and
metabolized rapidly in the liver (Arundel, 1983).
2.2.3 Macrocyclic Lactones
The macrocyclic lactones (avermectins and milbemycins) are products or chemical
derivatives of soil microorganisms belonging to the genus Streptomyces. The first generation
avermectins in commercial use are ivermectin (Ivomec® and Primectin®), abamectin, doramectin
(Dectomax®), eprinomectin (Eprinex®), and selamectin. Second generation commercially
available in the United States are milbemycins (milbemycin oxime and moxidectin,Cydectin®)
(Schoenian, 2012). The macrocyclic lactones have a potent, broad antiparasitic spectrum at low
dose levels. Macrocyclic lactones block the transmittance of electrical activity in nerves and
muscle cells by stimulating the release and binding of gamma-aminobutyric acid (GABA) at
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nerve endings. This causes an influx of chloride ions into the cells which leads to paralysis of the
pharynx thereby inhibiting pharyngeal pumping that is vital for feeding. Additional effects
include paralysis of the body wall and uterine muscles which inhibits motility and reproduction
of the nematode (Kahn, 2005).
Of the macrocyclic lactones, ivermectin, eprinomectin, doramectin, and moxidectin are
FDA-approved in various formulations including oral, injectable, and pour-on products for use in
cattle. Abamectin (Avomec®) is registered only in Australia. Ivomec, Primectine and Cydectin
oral are FDA approved for use in sheep. Ivermectin and moxidectin are also FDA approved as
oral and subcutaneous formulations for use in small ruminants.
In cattle, the macrocyclic lactones have a very high efficacy against all GIN stages,
including inhibited forms of the common GIN. They have been a more favorable class of
anthelmintic in cattle in that they provide a longer protection period against new GIN infections
after treatment. However, due to unfavorable dosing practices that permit the development of
drug resistance, their use has become less reliable in the small ruminant industry and recent
reports have demonstrated decreased efficacy in cattle (Anziani et al., 2004; Miller et al., 2007;
Edmonds, 2010).
In 1998, an oil-based, long-acting injectable formulation of ivermectin was registered in
Brazil and is available in most Latin American and African countries. In cattle, this formulation
offers treatment and prophylactic prevention of GIN and external parasites for up 77 d. Also, an
oil based long-acting injectable formulation of moxidectin was developed and is currently
registered in Latin America, Australasia, and some European countries. Controlled studies using
this long-acting moxidectin product showed parasite protection between 90 to 150 d against
some GIN infections (Ranjan et al., 2004). In the U.S., moxidectin is licensed for use in cattle,
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and comes in the form of a pour-on and injectable. This product, however, is not as long lasting,
as it provides effective anthelmintic activity for up to 42 days depending on the GIN species.
More recently, a long-acting injectable formulation of eprinomectin (LONGRANGE®) was
registered and FDA-approved for use in cattle in the U.S. Treatment provides persistent control
for 100–150 days, depending on the GIN species.
2.2.4 Amino-acetonitrile derivatives (AADs)
Amino-acetonitrile derivatives (AADs) are the most recent addition to the farm animal
class of anthelmintics. Monepantel (Zolvix®), the first drug in this class, is commercially
available in Australia, New Zealand, and Europe and is only intended for use in sheep.
Developed by Novartis Animal Health, monepantel is an oral drench that has a unique mode of
action. Monepantel causes paralysis in worms by binding to a specific receptor found only in
GIN. No other species of animal has been found to possess the specific receptor for the AADs
and this is believed to be the reason behind the high margin of safety in sheep as well as its high
level of environmental safety. Zolvix® is effective against adult nematodes, and normal and
inhibited L4. It is primarily used for the treatment and control of AAD-sensitive strains of GIN
and has been shown to be effective in reducing macrocyclic lactone, benzimidazole, and
imidazothiazole resistant strains in sheep (Novartis Animal Health, 2010). AADs have yet to be
evaluated in cattle, but may be available at some time in the future.
2.2.5 Miscellaneous Anthelmintics
Spiroindoles is also a new class of anthelmintic that was released in 2010. The only drug
in this class is derquantel. Derquantel has been approved in Australia and New Zealand as a
combination anthelmintic (Startect ®) in conjunction with the macrocyclic lactone drug,
abamectin. By combining these two drugs, the spectrum of parasite activity is enhanced by
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greater than 95%. When used together at the recommended dosage, Startect® is efficacious
against the adult and L4 stages of Trichostrongylus spp and Nematodirus spp. It also shows
activity against the adult stage of Haemonchus spp, and has demonstrated variable efficacy
against Teladorsagia circumcinta and the L4 stages of H. contortus, as well as some
ectoparasites. It is not approved for use in the U.S (Little, 2011).
Clorsulon is a sulfonamide given orally as a suspension and is primarily used to control
immature and adult liver fluke infection in cattle and sheep. In cattle, it can also be used in
conjunction with ivermectin (IvomecPlus®) as an injectable. In plasma, clorsulon is bound to
protein and, when ingested by liver flukes, inhibits enzymes of the glycolytic pathway. Clorsulon
has a wide safety margin and FDA-approved for use in cattle only as IvomecPlus®. The one
drawback of this formulation is that the amount of clorsulon is less than the full dose and
therefore only has activity against adult liver flukes. (Fetterer, 1985).
2.3 Anthelmintic Resistance in Ruminants
GIN are the most common parasites causing disease in grazing ruminants worldwide and
resistance to anthelmintics has become an issue. Resistance is generally defined as a decrease in
anthelmintic efficiency against GIN that are usually susceptible to the anthelmintic at the
recommended dose and is an inherited trait (Sangster, 1999). Factors that play a role in resistance
may include continuous and/or frequent usage of the same group of anthelmintic, incorrect or
subtherapeutic dosing of the drug, and prophylactic mass treatment of all animals in the flock or
herd (or lack of refugia). Excessive use of anthelmintics select for GIN in the population that
have mutations that confer resistance to that drug. Repeated anthelmintic treatments of the same
drug allows the resistant population to build up and they may also become resistant to other
drugs in the same class. Under dosing is also an important factor in the development of
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resistance. Many laboratory experiments have shown that under dosing an animal causes
subtherapeutic levels of the drug in the animal and may contribute to the selection of resistant or
tolerant strains. Also, treating all animals in the group can result in a large pool of resistant
genes. When every animal in the group is treated with an anthelmintic, essentially all susceptible
worms will be killed leaving only resistant worms to reproduce and pass down this gene to their
offspring (Waller, 1994). This could potentially result in an almost completely resistant
population of GIN. When a proportion of worms in a population is unexposed to an anthlemintic,
those worms reproduce and can help maintain the genes for susceptibility within the population.
This concept is known as refugia. By maintaining refugia, livestock producers can conserve the
efficacy of anthelmintics (Van Wyk, 2001). Refugia has not been extensively studied in cattle,
but considering the positive effects extrapolated from the small ruminant industry, cattle
producers could potentially slow the development of resistant parasites by implementing refugia
in their management practice.
The first examples of anthelmintic resistance were reported for H. contortus in small
ruminants dating back to the 1960’s (Smeal et al., 1968). Resistant strains of H. contortus remain
as the most serious health issues in small ruminants today. The first documented case of
resistance in GIN of cattle in the US was reported in an intensively grazed stocker operation that
also practiced strategically-timed deworming for over 17 years (Gasbarre, 2009a). The results of
that study demonstrated the presence of anthelmintic resistance to moxidectin and a
benzimidazole, and the predominant surviving GIN was C. punctata. Since then, multiple reports
have surfaced documenting an increasing problem of anthelmintic resistance in cattle (Anziani,
2004; Edmonds, 2010; Gasbarre, 2009b). To assess the extent of the issue in cattle in the U.S., a
survey was initiated in 2008 by the United States Department of Agriculture, National Animal
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Health Monitoring System. The study revealed that more than one-third of the cow/calf
operations participating in the study had less than 90% fecal egg reduction. PCR analysis showed
that Cooperia spp. were the most resistant GIN. These operations had used either an injectable or
a pour-on formulation of either a brand name or a generic macrocyclic lactone (Gasbarre, 2014).
Another study revealed that treatment with injectable ivermectinwas not effective at removing
adult Cooperia spp. and inhibited O. ostertagi at drug levels consistent with label claims
(Edmonds, 2010).
Resistance has been well documented in small ruminants to every GIN involving many of
the conventional drugs in multiple classes of anthelmintics (Shalaby, 2013). This has led the
small ruminant industry to extensively research alternate methods of GIN prevention and control.
Results of recent research has shown promising hope in GIN treatment and prevention in small
ruminants through the use of methods that do not involve the use of anthelmintics. Such methods
include the nematode trapping fungi (Duddingtonia flagrans), condensed tannin containing
plants, vaccines, and copper oxide wire particles. Copper oxide wire particles and sericea
lespedeza (condensed tannin containing plant) have both shown some activity against GIN in
cattle. (J.E. Miller, personal communication).
2.4 Novel Gastrointestinal Nematode Control Strategies
Duddingtonia flagrans is also known as a nematode trapping fungi. This fungus produces
thick-walled chlamydospores that are able to survive passage through the ruminant’s
gastrointestinal tract. The chlamydospores can be processed into a granular or dry powder
supplement feed form and are mixed in with the ruminant’s diet. This form of control has largely
been studied in small ruminants and is effective in reducing pasture infectivity by disrupting the
parasite’s life cycle. The infective L3 is captured by networks of sticky traps before it migrates
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out of feces and onto the forage. The fungus feeds on the L3 thereby decreasing the chance for
an animal to become infected (Larsen, 2006). There have also been studies using this fungi as a
biological control method in cattle in Brazil (Assis et al., 2012). Although the study showed
effectiveness in controlling bovine GIN in tropical conditions, questions were raised as to
whether this method can be used in various climates, different types of cattle operations, and the
effectiveness and ability to expose every animal in the herd. To date, no trials in the United
States have been documented using D. flagrans in cattle.
Several tannin-containing forages, in particular those with condensed tannins (CT), have
shown anthelmintic activity against GIN of sheep and goats (Shaik et al., 2006). These plants
could act through direct antiparasitic activity but they also act indirectly by increasing host
resistance. Sericea lespedeza (SL), a perennial legume containing a high level of CT, can be fed
to ruminants in various forms which include forage, hay, and pellets. The forage form is known
to have a bitter taste, which creates a palatability issue. Problems with SL in hay formulations
occurs as plant material is lost during processing. In cattle, tannin-containing plants have shown
to reduce the incidence of pasture bloat (McMahon et al., 2000). Because tannin-containing
plants show anti-parasitic properties in small ruminants and nutritional benefits in large
ruminants, there is reason to believe they may be useful in cattle for their antiparasitic effects.
The only study to date evaluating the CT as a biological control for cattle GIN was done in 2011
in an in vitro setting, and results were determined by a larval inhibition assay and a larval
exsheathment assay (Novobilský, 2010). Results indicated that extracts inhibited Ostertagia and
Cooperia larval development.
Vaccinating ruminants to control GIN infections has been a consideration. The most
practical reason to vaccinate against these parasites is to reduce reliance on anthelmintics. The
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use of vaccines may offer multiple benefits such as improving animal health and welfare, solving
problems associated with resistance to anthelmintics, and keeping animals and the environment
free of chemical residues. Vaccines have been developed to aid in the control of the lungworm,
Dictyocaulus viviparous, in young cattle (Bovilis® Huskvac, MSD Animal Health, U.K), and
tapeworms in sheep, but currently there are no vaccines commercially available for the control of
GIN in ruminants. There have been two immunization studies investigating vaccine use to
control O. ostertagi in cattle using L4 extracts (Halliday et al., 2010; Meyvis et al., 2007). These
studies, performed in Europe and the U.K, have shown variable results in the reduction of FEC
and L4 larvae. Further investigation is warranted to determine the exact mechanisms at work in
these cases.
Copper oxide wire particles (COWP) have anti-parasitic properties when administered
orally and added to the diet of small ruminants. Many studies have shown a significant
relationship between COWP and a decrease in FEC of GIN, specifically H. contortus. The exact
mechanism of how COWP control internal parasites is not yet fully understood. Copper boluses
(Copasure©) are available for use for copper deficiency in cattle, but lacks research in
determining if it aids in controlling GIN in cattle.
Although these novel methods of control show promising hope for the future of the small
ruminant industry, they have not been extensively studied in cattle and are not yet available for
commercial use in the U.S. These methods may also lack the value of convenience that cattlemen
desire when choosing a strategic deworming method.
2.5 Current Gastrointestinal Nematode Control and Prevention Methods in Cattle
Current treatment of GIN in cattle today greatly relies on the macrocyclic lactones (ML)
(Ballweber and Baeten, 2012). As a class, these drugs are known to be extremely effective at low
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dosages, provide very high efficacy against a broad range of GIN and external parasites, achieve
persistent blood levels, and can prevent reinfection from certain parasites for weeks after a single
treatment. A recent survey indicated that 88% of bovine anthelmintic sales were MLs and 12%
were benzimidazoles in the United States (McArthur, 2014). The MLs can be delivered in
various forms such as injectable, oral, or topical routes, and all portray a wide safety margin. Use
of older anthelmintics in cattle, such as the benzimidazoles and imidazothiazoles have decreased
substantially. Reasons for the decline in use of those drugs is likely due to decreased efficacy as
compared to MLs. When topical MLs were formulated, consumer preference narrowed even
more because they were convenient and ultimately reduced stress and the labor cost associated
with handling and treating herds of cattle (Gasbarre et al., 2009). Drugs in this class, such as
eprinomectin and moxidectin pour-ons, have no milk withdrawal time in many countries. This
feature also contributes to its popularity. Because of the potency, convenience and low cost,
cattlemen may be reluctant to discontinue use of the MLs. Until other anthelmintic alternatives
can be shown to consistently reduce GIN infections in real life practice, increase economic
benefits, and demonstrate sustainable efficacy, it is not likely that cattle producers will stray
away from current deworming practices.
Pour-on formulations have been the method of choice by many cattlemen and
veterinarians because administration of the drug is easy and places less stress on the animal.
Although these pour-ons seem to be convenient, there is great variability in the amount of drug
each animal receives. Multiple studies have shown that grooming habits of other animals can
influence the actual amount of drug that enters the body (Sallovitz et al., 2002, 2003). This drug
delivery method can result in under dosing an animal, which in turn contributes to the increase in
anthelmintic resistance. At this time, cattlemen are reluctant to try alternative anthelmintic
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strategies due to the ease of administration and cost effectiveness of injectables and pour-ons.
This stresses the importance of the development of new products and methods that can deliver
extended parasite protection thereby reducing the labor intensive nature of current products.
Successful anthelmintic strategies should involve developing a program with the goal of
maximizing the economic benefit while also reducing egg/larval contamination on pastures.
Incorporating knowledge from the host–parasite–environment relationship in addition to
developing extended pharmacological properties of anthelmintics can help to prolong efficacy of
existing anthelmintics. Recently, there have been new strategies to optimize the use of existing
anthelmintic drugs, as well as secure an extended use of the novel products, and to control
resistant parasites from a pharmacokinetic-based enhancement of parasite exposure. The newest
product to display these properties involves the use of an extended-release injectable
anthelmintic that contains a unique delivery system that releases the active ingredient in two
peaks resulting in extended anthelmintic activity.
2.5.1 Extended-Release Injectable
Recently, an eprinomectin extended-release injection formulation (LONGRANGE®, ELR) was developed by Merial to provide long-term GIN control in cattle. E-LR is composed of a
5% sterile solution of eprinomectin, and administered at a rate of 1mg/kg of body weight. The
eprinomectin is formulated in a solvent that includes a polymer matrix, which slowly releases the
active ingredient following injection. E-LR is the first extended-release anthelmintic that claims
to provide up to 100 to 150 days of GIN control in a single treatment depending on the species of
GIN. Eprinomectin is not bound by the animal’s fat cells in the tissues, instead after delivery it
enters the animal’s bloodstream through the trademarked breakthrough technology called
Theraphase.
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According to Merial, the pharmacokinetic properties of this product allow the gradual release
of the active ingredient in two peaks. The first peak is immediately after the initial subcutaneous
injection. Once in the body, the liquid polymers solidify into a gel to create the trademarked
Theraphase matrix, which encapsulates the eprinomectin. From this gel matrix, the drug is
released into the bloodstream over an extended period of time. Following the first initial peak,
plasma concentrations start to decline and by d 25 the level is low and constant to approximately
d 70. Following d 70, the Theraphase matrix begins to disintegrate and a second bolus of
eprinomectin is released, creating a secondary peak in the blood stream around d 90-100.
Thereafter, the drug gradually declines until around d 150. The gel matrix biodegrades by
hydrolysis and is eliminated from the body as carbon dioxide and water. Clinical studies done by
Merial have shown plasma concentrations of eprinomectin between 0.5 ng/mL and 1.0 ng/mL
are the minimal drug level for nematocidal activity. While the drug is decreasing in
concentration, it constantly stays at therapeutic levels with a blood concentration of 1.0 ng/mL or
higher until day 150 where the concentration falls to 0.5 ng/mL Because the Theraphase matrix
allows for the controlled release of the drug into the animal’s system, it can therefore exit the
body quickly before lingering around at sub-therapeutic blood levels. This advanced delivery
system is thought to minimize the selection for resistant parasites.
E-LR has been shown to be effective against several GIN stages including L4 and adults.
Based on the results of these studies, claims were granted to control multiple GIN parasites
including C. oncophora, C. punctata, C. sumabada, H. placei, O. radiatum, O. lyrata, O.
ostertagi, T. axei, and T. colubriformis. This product also shows efficacy against O. ostertagi
inhibited L4. Merial’s confirmation studies showed control of C. oncophora, C. punctata, and T.
axei up to 100 d, while H. placei, O. radiatum, O. lyrata, and O. ostertagia were effectively
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controlled up to 120 d. The pulmonary nematode, D. viviparous, is the only parasite confirmed to
be controlled up to 150 d.
Formulations that provide extended periods of GIN control are thought to not only treat
existing infections within the host, but also to prevent the host from becoming reinfected with
L3. Because L3 can overwinter, they can infect cattle as soon as they are turned out into pasture
during the next grazing season. When the environmental conditions become favorable, the L3
move up grass blades and are ingested by the grazing cattle. The L3 transition to adults and
millions of eggs are passed onto the pasture where the next grazing cycle begins. This process
can also occur during hot and dry periods during the summer months. The L3 remain under the
root mat and can move into the soil seeking moisture and cooler conditions for protection and
survival. Once the environmental conditions improve, the L3 are able to migrate up the grass
blades to infect the animal. To break this cycle of infection and reinfection, it takes about 100 d
of continuous treatment to reduce the GIN burden in the animal and subsequent pasture
infectivity. Conventional dewormers such as moxidectin (Cydectin®), doramectin (Dectomax®)
and eprinomectin (Eprinex Pour-On®) control GIN and lungworms for up to 42 d. These
anthelmintics may reduce the GIN burden in the animal short term. However, sequestered L3 on
the pasture that become active again after 42 d can infect the animal with no anthelmintic activity
present to kill new ingested L3. This may contribute to the lack of reduced pasture infectivity
when using an unsustainable anthelmintic.
GIN infection can affect many aspects in a cow/calf operation. The physiological tasks of
a heifer calf include growth, reproductive competence, gestation, lactation, and post-partum
rebreeding. Post-partum rebreeding constitutes the biggest issue for heifers during development
(Perry et al., 2011). The greatest factor affecting first calf heifers and young cattle’s rebreeding
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ability is their plane of nutrition (Lemenager et al, 1980). When GIN adversely affects the
animal’s nutritional efficiency and body condition, this reduces conception rates and milk
production. Although peak lactation is variable from animal to animal, it generally occurs around
45-60 d post-calving. Also during this time, heifers lose weight and body energy reserves are
depleted. When L3 are ingested after anthelmintic activity wanes, the animal’s ability to
maintain their body condition is compromised. Also, infected animal may be rendered
susceptible to other infectious diseases. Because eprinomectin is released again around d 70
when treated with E-LR, this may have a positive effect on the animal’s ability to maintain
nutritional status, thus increasing ability to rebreed and generate profit for the producer. One
study, conducted by Merial, compared heifer weight gain following treatment with doramectin as
the control anthelmintic and E-LR as the treatment anthelmintic. The calves treated with E-LR
showed s significant (P < .001) increase in mean gain per head of 11.5 kg.
There have been reports of a positive association between deworming nursing calves and
an increase in weaning weight (Miller and Morrison 1990ab; 1992). However, producers might
not view that cost benefit as productive especially if it means increasing stress, labor, and time
by putting the herd through the chute multiple times. Because E-LR administered at the
beginning of the grazing season may provide long-term control for the whole grazing season, the
end result may be more acceptable. In cow-calf operations, it’s very important to make sure
calves are healthy which, in turn, will provide a weaning weight that other segments in the beef
production system will be willing to purchase. According to a clinical field study done by
Merial, the use of a long-acting anthelmintic demonstrated production benefits in young growing
stocker steers. Steers were treated with either E-LR or moxidectin + fenbendazole , and the
results showed that E-LR treated steers had a significant (p < 0.001) increase of 18.2 kg more
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than control steers. One area of concern with using long-acting anthelmintics in calves in their
first grazing season is the reduction of the animal’s ability to develop adequate acquired
immunity to GIN infection. These young calves may become more susceptible to the adverse
effects of reinfection from grazing after protection from the anthelmintic wears off. One report
showed that FEC was significantly (p < 0.05) higher in second season grazing animals that had
been dewormed during their first grazing season, which suggested that the immunity to GIN may
be reduced (Larsson et al., 2011). However, no differences in weight gains were observed in the
second grazing season, despite the animals being subjected to different means of parasite control
during their first season of grazing. This is in accordance to a similar study in which there was no
observation of any negative impact of previous anthelmintic treatment of heifers despite a higher
burden of adult O. ostertagi in those animals (Satrija et al., 1996). However, these studies used
repeated administration of conventional anthelmintics. Therefore, the use of long acting
anthelmintics such as E-LR may also reduce pasture infectivity to a level where reinfection is not
adequate enough to maintain a strong level of immunity and subsequent infection may be worse
than the initial infection.
The general idea surrounding the use of E-LR is to reduce the susceptible GIN burden for
a prolonged period of time and therefore improve the nutritional status and weight gain. Fecal
egg count reduction tests, larval cultures, and weight gain studies have provided evidence that ELR is effective in doing that. Short-term products may reduce the GIN burden, but lack the
ability to provide protection when it is needed the most, such as when inhibited O. ostertagi L4
resume development in the early fall. By using E-LR in cow-calf operations, there may be a
potential for increasing profit when considering reduced labor, less stress on the animal, decrease
in numbers of GIN, increase in weaning weights, and improved nutritional efficiency. It may also
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be beneficial to use E-LR in an integrated control strategy with non-drug methods such as
COWP, CT containing forage, nematode-trapping fungi, etc. Additionally, by treating one
population of animals (either the young calves or older cows), the concept of refugia may be
enhanced naturally. This clinical trial assessed E-LR in naturally infected young 2-4 m old calves
as they co-grazed with their dams on pasture for effect on infection and weight gain during hot
summer climatic conditions in central Louisiana
.

29

CHAPTER 3
MATERIALS AND METHODS
3.1 Location and Animals
This study was conducted at the LSU Dean Lee Research Station in Alexandria,
Louisiana and consisted of 67 bulls and 53 heifer calves. All calves used in this study were
spring born with birth dates ranging from February 2014 through April 2014. The average age of
the calves at the beginning of treatment was approximately 4 months. Groups A and B consisted
of 34 bulls and 25 heifers; 37 of which consisted of Brangus-sired breed and 22 were Simmentalsired. Groups C and D had 33 bulls and 27 heifers; 31 of those calves were Brangus-sired breed
and 29 were Simmental-sired. The average birth weight of calves in all 4 groups was 40 kg. The
health condition of every animal prior to and during the study was supervised by a licensed large
animal veterinarian.
3.2 Source of E-LR
E-LR was provided by Merial, a global animal health company.
3.3 Experimental Design
3.3.1 Study
This study consisted of 120 resident cow/calf pairs that were randomly allocated
according to breed, sex, and weight to 4 different groups (A, B, C, and D) of 30 hd each. All
animals in the study were allowed to graze on pasture for the entire length of the study. The
duration of the study was 112 d (6/4/14-9/29/14). Each group was rotated throughout all pastures
to allow equal parasitic exposure. Calves in groups A and B were treated with the control
anthelmintic, fenbendazole (F-P, Panacur® Suspension 10%, 10mg/kg, Merck Animal Health,
Madison, NJ), administered orally. Calves in groups C and D were treated with E-LR (5% sterile
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solution, 1 mg/kg, Merial, Duluth, GA), administered subcutaneously cranial to the left shoulder.
All treatments were given by a licensed large animal veterinarian.
On d 0, calves were brought in from the pasture and processed individually through a
chute to identify the animal according to its ear tag and electronic identification, and to confirm
the animal’s group letter. Calves were then treated with the appropriate anthelmintic, a fecal
sample was obtained, and their initial weight was recorded. Following treatment, calves were
designated to their corresponding location for each group, A-D. All calves were worked through
the chute on d 14, 28, 56, 84, and 112 and each calf was weighed and a fecal sample was
obtained. All fecal samples were stored at 4˚C to be processed to determine FEC, expressed as
eggs per gram (EPG) and cultured to determine GIN population distribution.
3.4 Techniques
3.4.1 Fecal Egg Count
Fecal samples were obtained directly from the rectum, placed in styrofoam cups and
sealed with a lid. These samples were taken directly to the Department of Pathobiological
Science lab to be analyzed for FEC using the McMaster technique (Whitlock, 1984). Two g of
feces from each animal were broken up with a tongue depressor. Thirty mL of a saturated salt
solution (737 g of iodized salt dissolved in 3000 mL of tap water) were added to the feces and
the solution was mixed using an electric drink mixer (Drinkmaster ® Drink Mixer, Hamilton
Beach Brands, Inc., Glen Allen, NC). A sample of the mixture was then rapidly pipetted and
transferred into one side of the McMaster chamber. The solution was again mixed using the
Drinkmaster for the same amount of time and a second sample was quickly transferred into the
other chamber on the McMaster slide. All trichostrongyle type eggs were counted using 100x on
a microscope. This technique was performed in duplicate on each calf on d 0, 14, 28, 56, 84 and
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112. The total number of eggs on both sides of the McMaster chamber was multiplied by 50 to
obtain the EPG. The duplicate samples were then averaged to obtain the final EPG for each calf.
Furthermore, samples with a zero McMaster FEC were processed by the double centrifugation
technique to obtain a FEC less than 50 EPG.
3.4.2 Double Centrifugation (Sugar Float)
The Double Centrifugation technique is used to concentrate eggs in the sample using a
highly concentrated sugar solution and is useful when FEC are low (usually less than 50 EPG).
Two g of feces were broken up in individual cups with a wooden spatula. Fifteen mL of water
was added to the cup and mixed extremely well, making sure to break up any clumped feces.
This solution was then poured through a strainer and funnel into a 15 mL centrifuge tube;
remaining fecal material left on the strainer was pressed against the strainer with a mortar stick to
release as much solution as possible into the tube. Sample tubes were placed in centrifuge
buckets and spun for 5 min at 1500 rpm. The supernatant was then discarded and a sugar solution
(1600 mL sugar and 400 mL of water) was added to each tube until the tube was half full. The
solution was stirred well with two applicator sticks to break up concentrated fecal material at the
bottom of tube. Tubes were then placed back into the centrifuge where the sugar solution was
poured to fill the tube to a positive meniscus. A cover slip was placed on top and tubes were spun
again for 5 min at 750 rpm. Following centrifugation, the cover slips were placed on microscope
slides. All trichostrongyle type eggs were counted using 100x on a microscope.
3.4.3 Fecal Larval Coprocultures (Bulk Cultures)
Fecal samples obtained from all calves in each group were mixed together in bulk and
cultured to allow GIN eggs to hatch and develop to L3 for recovery, enumeration, and
identification. Larval cultures were made from fecal samples obtained on d 0, 14, 28, 56, 84, and
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112. Feces from each animal were combined according to group and sample date. Total weight
of feces was then recorded and feces were divided into thirds (triplicate) as evenly as possible
into separate plastic bins. Feces were then broken up and vermiculite was combined with feces in
an approximately 50:50 by volume mixture. Water was added to all samples until a crumbly
moist consistency was achieved. Each bin was covered with aluminum foil and holes were poked
in foil to allow oxygen exchange. Cultures sat at room temperature (about 25°C) for 14 d, and
were then processed by the Baermann technique to recover L3.
3.4.4 Baermann Technique
The Baermann technique was used to aid recovery of L3 larvae from bulk cultures. A
wire screen was placed into the opening of a large funnel. A 15 mL plastic centrifuge tube was
used to collect L3 beneath each funnel by attaching it to the bottom of the funnel with a short
rubber hose. A piece of cheesecloth large enough to cover the screen was laid out on a flat
surface and culture samples were carefully poured into the center of the cloth. The sides of the
cloth were wrapped and tied around the sample. The wrapped sample was placed onto the wire
screen in the funnel and warm water was added to the funnel to completely submerge the sample.
The sample was allowed to sit for 24 h. A small amount of formalin was added to all samples
collected in the tubes to preserve L3 for later identification.
3.4.5 Larval Counts and Identification
The supernatant in the 15 mL tube was vacuumed to 1 mL. A pipette was used to draw up
a 100 uL aliquot which was placed on a microscope slide. A drop of iodine (150 g potassium
iodide and 100 mL water) was mixed into the aliquot, and a cover slip was placed on top of the
drop. L3 were then enumerated using 100x on a microscope. The first 100 or total (if the total
was less than 100) L3 were identified to genus to estimate population percentages.
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3.4.6 Fecal Egg Count Reduction Test
The FEC reduction test was used to determine the efficacy of treatments. This test
compares the FEC of the treatment groups on d 0 and d 14. The formula for this calculation was:
Pre-treatment – Post-treatment/Pre-treatment x 100.
3.5 Statistical Analysis
Data were analyzed using SAS® (version 9.4) as a repeated measures analysis of
variance using PROC MIXED. The initial FEC values, and initial LOG FEC values (d 0) were
used as a covariate. The response variables were the subsequent FEC values (for the remaining
study days), LOG FEC values, and weight. Weight was analyzed independently of FEC. Fixed
effects included treatment and time. Random effects include animal identification within
treatment group. When overall differences were found, post hoc comparisons were conducted
with pairwise t-tests of least-squares means. All differences were considered significant at P ≤
0.05
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CHAPTER 4
RESULTS
4.1 Study 1 Results

At the beginning of the study on d 0, all calves had relatively low FEC (Figure 1).
Subsequent to treatment with F-P or E-LR, the mean FEC of calves in all 4 groups decreased by
d 14. On d 14, mean FEC in all 4 groups was comparatively similar and no significant difference
(P > .05) was detected between any of the groups (Figure 1 and 2). Also on d 14, the FEC
reduction test showed 95.15% and 93.64% reduction for F-P and E-LR treated calves,
respectively. Between d 14 and d 28, the mean FEC for all 4 groups remained fairly constant
with no significant differences (P ≥ 0.05) (Figure 1). However, the mean logFEC did show
significant differences (P < 0.05) on d 28 between groups A and C, and B and D (Figure 2). After
d 28, the mean FEC of calves treated with F-P in groups A and B increased, while the mean FEC
of calves treated with E-LR in groups C and D remained constant. On d 56, significant
differences (P < 0.05) were found between groups B and C, and B and D (Figure 1). The mean
logFEC showed significant differences on d 56 between A and C, A and D, B and C, and B and
D (Figure 2). Mean FEC of calves in all groups then increased by d 84. A significant difference
(P < 0.05) was detected again between groups A and C, A and D, B and C, and B and D (Figures
1 and 2). There was also a significant difference (P < 0 .05) on d 84 within the two F-P groups
and the two E-LR groups (Figures 1 and 2). Groups A and B continued to increase after d 84
reaching a mean FEC of 107 EPG and 157 EPG, respectively, on d 112 (Figure 1). Also between
d 84 and d 112, group C remained constant with a mean FEC of 29 EPG, while group D
increased to 29 EPG (Figure 1). There was a significant difference (P < 0 .05) on d 112 between
groups A and C, A and D, B and C, and B and D (Figures 1 and 2). A significant (P < 0.05)
difference was also observed between the two F-P treated groups, while there was no significant
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(P > 0.05) difference between the two E-LR treated groups (Figures 1 and 2).
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Figure 1. Mean (±SEM) fecal egg count (FEC) on d 0, 14, 28, 56, 84, and 112 for fenbendazole
(F-P, Panacur®,10mg/kg, drench) and eprinomectin (E-LR, LONGRANGE®,1mg/kg, SQ
injection) treated calves. N = 30/group. *Indicates significant difference (P < 0.05) between
group A (F-P) and at least one or more E-LR treated groups.
~Indicates significant difference (P < 0.05) between group B (F-P) and at least one or more E-LR
treated groups.
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Figure 2. Mean (±SEM) log fecal egg count (logFEC) on d 0, 14, 28, 56, 84, and 112 for
fenbendazole (F-P, Panacur®, 10mg/kg, drench) and eprinomectin (E-LR, LONGRANGE®,
1mg/kg, SQ injection) treated calves. N = 30/group.
*Indicates significant difference (P < 0.05) between group A (F-P) and at least one or more E-LR
treated groups.
~Indicates significant difference (P < 0.05) between group B (F-P) and at least one or more E-LR
treated groups.

The mean FEC of the calves that were treated with F-P were combined, and the mean
FEC of the calves treated with E-LR were combined (Figure 3). The mean FEC was similar (P >
0.05) between F-P and E-LR treated calves on d 0. By d 14 and 28, FEC decreased and was
similar (P > 0.05), indicating the treatment was successful. By d 56, the mean FEC of calves in
both groups increased; however, the degree of increase in calves treated with E-LR was not as
pronounced as the F-P treated calves. After d 56, this trend of increasing FEC continued in both
groups, with the F-P treated calves having higher (P < 0.05) FEC. On day 84, there was an
increased difference (P < 0.05) in FEC between calves treated with F-P and calves treated with
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E-LR. The difference between groups was even more noticeable (P < 0.05) on d 112 as the mean
FEC of F-P treated calves was approximately 4.5 times higher than E-LR treated animals.
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Figure 3. Mean fecal egg count (FEC) of combined fenbendazole (F-P, Panacur®, 10mg/kg) and
eprinomectin (E-LR, LONGRANGE®, 1mg/kg) treated calves on d 0, 14, 28, 56, 84, 112. N =
60/group.
*Indicates significant difference (P < 0.05) between groups.

To determine differences in weight gain, the mean weight of both F-P and E-LR treated
groups were calculated on d 0 and 112 (Figure 4). The mean weight gain for F-P treated calves
(groups A&B) was 114.1 kg and 116.4 kg, respectively, and the mean weight gain for E-LR
treated calves (groups C&D) was 110.9kg and 114.1 kg, respectively. There were no significant
differences (P > 0.05) in weight gain between any of the groups at any time point in the study.
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Figure 4. Weight at beginning and end of study for fenbendazole (F-P, Panacur®, 10mg/kg, (n =
59) and eprinomectin (E-LR, LONGRANGE®, 1mg/kg (n = 61) treated calves.

Data from fecal bulk cultures were used to determine the population distribution of GIN
in the calves (Table 1). The predominant GIN throughout the study were Cooperia (46% and
49% for F-P and E-LR, respectively) and Ostertagia (49% and 50% for F-P and E-LR,
respectively) with Haemonchus and Trichostrongylus being present in relatively low numbers. A
few Oesophagostomum were found (<0.2%). It should be noted that the standard amount of 100
L3 used to establish a distribution population were not always able to be recovered because of
such low FEC (Figure 5). On day 0, the total number of L3 recovered from feces of calves
treated with F-P and E-LR was 600 and 585, respectively. After treatment, on d 14, the total
number of L3 recovered was 11 and 26, respectively. These numbers continuously increased in
F-P treated calves throughout the rest of the study. Whereas, the total number of L3 recovered
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from feces of E-LR treated calves stayed comparatively low during the rest of the study. On d
112, the total number of L3 recovered from feces of F-P and E-LR treated calves was 600 and
64, respectively. Overall, the total number of L3 recovered from feces of E-LR treated calves on
d 28, 56, 84, and 112 was considerably less than the total number recovered from F-P treated
calves (Figure 4).

Table 1. Percent infective larvae recovered from fecal bulk cultures of calves treated with
fenbendazole (F-P, Panacur®, 10mg/kg drench) and eprinomectin (E-LR, LONGRANGE®,
1mg/kg SQ injection). H, T, C, Oe and Os = Haemonchus, Trichostrongylus, Cooperia,
Oesophagostomum and Ostertagia.

F-P
Day
0
14
28
56
84
112
Total

%H

%T

%C

%Oe

%Os

8
0
0
1
7
2
3

2
0
10
1
1
0
2

41
10
43
62
58
61
46

0
0
0
0
0
0
0

49
90
47
36
34
38
49

0
0
0
0
0
0
0

63
28
30
32
85
65
50

E-LR
0
14
28
56
84
112
Total

3
47
3
24
0
0
13

2
0
49
6
0
3
10

33
25
18
38
15
33
27
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Figure 5. Total number of infective larvae (L3) recovered from feces of calves treated with
fenbendazole (F-P, Panacur®, 10mg/kg) and eprinomectin (E-LR, LONGRANGE®, 1mg/kg).
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CHAPTER 5
DISCUSSION AND CONCLUSION
With increasing reports of production losses caused by recurrent GIN infections, cattle
producers are exploring new methods of long term prevention. The objective of this study was to
determination the efficacy of treatment with E-LR compared to treatment with F-P for 112 days
during natural pasture infection in young nursing calves. For information purposes, the degree of
a mixed GIN infection in cattle is considered light with an FEC up to 200 EPG, moderate with
200-800 EPG, and heavy when higher than 800 EPG.
The present study revealed that E-LR was more efficient at providing GIN control
compared to F-P. It was noted that FEC of E-LR treated calves was similar before treatment and
at the end of the study. This does not concur with the claim that the product provides protection
for 100-150 d post treatment. It was expected that the FEC would remain similar from d 14 to the
end of the study, but reinfection was not curtailed enough to see that effect. Reinfection did
occur to allow FEC to return to pre-treatment level by d 84. Therefore, under the conditions of
this study long term efficacy was about 84 d.
Both F-P and E-LR treated calves started the study with very low FEC and by d 14 both
treatments significantly reduced FEC and there was no significant difference between treatments.
This indicated that, based on the fecal egg count reduction test, both F-P and E-LR effectively
removed the GIN burden within the period of time that is used to determine efficacy (i.e., d 14).
The trend after d 28 is when the differences in FEC became more prominent. By d 56, there was
a distinct increase in FEC of F-P treated calves. This correlates well to the life cycle of GIN and
the length of protection provided by F-P. The life cycle of these GIN is approximately 42-56
days but can vary depending on the genus. These results suggest that F-P was efficient at killing
GIN initially for approximately 2-3 d, but after that reinfection is not affected. This is consistent
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with published reports that the period of activity of F-P is about 2-3 days (Lanusse, 1993). E-LR
treated calves, however, showed only a slight increase in FEC after d 56. This increase was
noticeably minimal compared to the F-P treated calves. The mean FEC at the end of the study in
groups A and B was 132, while the mean FEC in groups C and D was 29. This indicated that ELR effectively provided long-term parasite control and was efficient in preventing reinfection.
Preventing reinfection correlates to reduced pasture contamination, and the end result is calves
grazing on cleaner pasture.
In this same study, weight gain was also evaluated to determine if treating with E-LR
would result in calves gaining more weight than animals treated with F-P. This is important as
calves with higher weaning weights could potentially benefit a cow-calf producer. The calves
treated with E-LR, however, did not gain more weight compared to the calves treated with F-P.
One reasons for this may be due to the fact that all of the calves in the study had relatively low
FEC throughout the duration of the study even though F-P treated animals did show a significant
increase in FEC after d 28. A follow up study would be appropriate to compare these
anthelmintic treatments on moderate and heavily infected calves as weight gain might be
expected to be more of an issue under that circumstance.
Larval identification was performed to determine the trichostrongyle type GIN that were
present. Ostertagia and Cooperia were the predominant L3 recovered from feces of both F-P and
E-LR treated groups with more Ostertagia recovered than Cooperia. This is in contrast to a
previous report where Haemonchus and Cooperia were predominant during the summer in
Louisiana (Miller, 1993). As mentioned earlier, Ostertagia usually become inhibited within the
animal during extremely hot environmental conditions, so it was expected to have more
Haemonchus and Cooperia present. Why this shift in population occurred is not known. Perhaps
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over the last 20 years or so, the environmental conditions have become more conducive for
Ostertagia development outside the host. Also, the total number of L3 recovered from feces of
E-LR treated calves was substantially less than that recovered with F-P treated calves. This
coincides with and was expected with the relatively low FEC of E-LR treated calves. Because
much fewer L3 were found in feces of E-LR treated calves, the resultant pasture infectivity
would be expected to be reduced. So, essentially, treating cattle with E-LR may be an efficient
means to help clean up pasture infectivity. Conversely, an opposite effect was observed in calves
treated with F-P where an increase in FEC and number of L3 would most likely result in
maintaining pasture infectivity at a higher level.
With the use of any anthelmintic, and especially with extended activity anthelmintics
such as E-LR, the issue of resistance always poses a concern for reduced efficacy. It is just a
matter of how much time it will take. The use of any extended release anthelmintic exposes the
worms to the drug over a prolonged period of time, which will allow more and more resistant
worms to survive and thus create an increased population of resistant worms while creating a
decreased population of susceptible worms (lack of refugia). This is what would be expected, but
the negative effects from selection pressures on GIN using a long acting anthelmintic treatment
has not been studied. It may be expected that plasma levels fall below the optimal therapeutic
level and then the drug would be present in the animal’s system at subtherapeutic levels. Merial,
however, has indicated this product is actually formulated to prevent this occurrence. This is
done by utilizing their trademarked Theraphase matrix gel. The active component, eprinomectin,
is delivered by SQ injection with the Theraphase matrix gel which releases an initial therapeutic
dose of eprinomectin into the animal’s bloodstream where the drug initially kills worms over a
relatively short period of time and then exits the animal’s system. The amount of time the
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residual drug stays in the body at sub-therapeutic concentrations is short, preventing prolonged
exposure. Then, after a period of about 70-80 d, there is another release of drug from the
Theraphase matrix gel which provides a similar period of activity. Thus, 2 phases of relatively
short activity combined to provide the extended activity. With judicious use of anthelmintics,
especially extended release ones like E-LR, hopefully, resistance can be delayed as long as
possible.
Another potential issue that needs to be considered with the use of this (and similar)
product is treating young calves before turnout in their first grazing season may reduce the
interaction between the calf’s immune system and the parasites to a level which might hinder the
animal’s ability to develop a protective immune response upon future exposure. Therefore, when
the prolonged period of activity wanes, the animal is left with reduced immunity which may
result in susceptibility to subsequent GIN infection. This concern would primarily affect stocker
producers, who normally purchase weaned calves right after their first grazing season. By the
time these calves reach their new location, the length of anthelmintic activity will be coming to
an end. If the calves are then put on a heavily infective pasture, they may not be able to
immunologically combat the deleterious effects of high parasite loads. This problem may not be
of much concern if calves are retained on the original operation and on the same pastures where
E-LR was used as pasture infectivity level should remain low.
Despite the conditions of this study where FEC was low for the entire period, E-LR still
shows promise in controlling GIN infection in nursing calves. Overall, E-LR was shown to
provide a more efficient and longer protection period than F-P offered; however, there was no
weight gain advantage. Further, investigations are needed to address concerns of increased
resistance, lack of refugia, and decreased immunity associated with this anthelmintic.
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